National Cancer Institute Pascale Foundation

Scientific director

Dott. Alfredo Budillon

The National Institute for Tumors “Pascale Foundation” is a Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) founded in 1933 by Senator Giovanni Pascale. It is an institution of national prestige with autonomy and legal entity, which, according to standards of excellence, pursues research objectives, mainly clinical and translational, in the biomedical field and the organization and management of health services and hospitalization and treatment of high specialty.

It represents the most prominent institution in Southern Italy and is the coordinator of the Campania Oncology Network established by DCA n°98/2016; it is also the reference center for the national oncology network.

The pursuit of the Institute is cancer prevention, diagnosis and treatment, and related research. It is a response for citizens to health needs, both from the perspective of recovery and maintenance.

The main feature that stands at the base of the mission is the ability to transfer research results and innovation to daily clinical activity. Indeed, research projects are strongly oriented to a translational purpose, assuming a continuous exchange of information between laboratory and clinical activity.

The centrality of the patient within the healthcare pathway includes ability to listen to the specific health needs expressed by the community and is the principle for the strategic choices of the Institute. The primary objective is to achieve excellence in preventing, diagnosing, and treating cancer diseases through clinical research and technological and management innovation.

The pre-clinical and clinical research conducted in the Institute is developed in four main macro-areas:

Macro-area 1 – Prevention and Risk Factors in Neoplastic Disease

Macro-area 2 – Tumor Markers and Innovative Diagnostic Procedures

Macro-area 3 – Integrated Treatments in Oncology

Macro-area 4 – Innovative Therapeutic Strategies in advanced stages of disease

Furthermore, the Institute bases its research and treatment of cancer pathologies on the following reference values:

centralization of the citizen-user concerning the organization of health services: the citizen figure is an essential element around which business decisions are developed;

flexibility of planning in alignment with the requests of its stakeholders: health care activities, by their nature, are not always standardized, allow maximum planning flexibility that can take into account the constant needs that come from users;

accessibility of services and health information: the Service Charter and Welcome Card (distributed by the URP) supports citizens in accessing health services. These traditional methods are also supported by the institutional web portal where all essential information is available;

certainty of health service quality and professionalism: the primary objective of the Institute is to guarantee citizen service quality offered as well as professionalism of health, administrative and technical resources that work with dedication and constancy;

User participation in the planning and monitoring of activities: the individual user participates in the evaluation of services provided by the Institute, with the results utilized for strategic and operational planning of the entire structure.

For some years, in the ongoing process of reviewing its role and functions, the Institute has been aiming to improve transparency towards stakeholders and promote privacy.

Healthcare is one of the most delicate sectors among those that must deal with the complex problems posed by privacy legislation, which has become a fundamental element in improving the quality of healthcare service.

In this context, the “Privacy Regulation,” was adopted as its correct application can only guarantee the dignity of patients.

The Associates

Consult the individual files of our Members

  • Founders
  • Ordinaries
  • Affiliates